Filing Flows › Health Catalyst (HCAT) › Q1 2025
Health Catalyst (HCAT) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
Health Catalyst (HCAT) reported revenue of $79.4M for the first quarter 2025 (Q1 2025), +6% from a year earlier and -0.2% from the quarter before. Operating margin was -25.4%, net loss $23.7M (29.9% of revenue).
Health Catalyst, Q1 2025: revenue $79.4M (+6% year over year), operating margin -25.4%, net loss $23.7M, operating cash flow $280K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $79.4M | -0.2% | +6% |
| Operating profit | −$20.2M | — | — |
| Net earnings | −$23.7M | — | — |
| Operating cash flow | $280K | — | -97% |
What changed
Revenue was $79.4M in Q1 2025, up 6% year over year and roughly flat from the previous quarter. Technology was the largest line at 65% of revenue. Technology added $4.5M year over year (up 10%), 96% of the total change.
Operating costs exceeded revenue by $20.2M, an operating margin of -25.4%. Total costs grew 2% against revenue growth of 6%. The fastest-growing cost line was Other operating costs (+17%). The quarter ended with a net loss of $23.7M, wider than the previous quarter's $20.7M loss.
Operating cash flow was $280K (down 97% year over year). Non-cash charges added back $12.3M of depreciation and amortization and $7.5M of share-based compensation. Working capital and other items added $4.2M. Capital expenditures of $670K exceeded it, leaving free cash flow of −$390K.
Questions
What was Health Catalyst's revenue in the first quarter 2025?
Health Catalyst (HCAT) reported revenue of $79.4M for the first quarter 2025 (Q1 2025), +6% from a year earlier and -0.2% from the quarter before.
Was Health Catalyst profitable in the first quarter 2025?
Operating loss was $20.2M (-25.4% of revenue) and net loss $23.7M.
Source: Health Catalyst 10-Q on SEC EDGAR.